Valuation: Medpace Holdings, Inc.

Market Cap 18.24B 16.33B 15.02B 13.61B 25.45B 1,732B 25.92B 179B 71.92B 911B 68.44B 66.99B 2,873B P/E 2026 *
35.8x
P/E 2027 * 33.2x
Enterprise Value 17.43B 15.61B 14.36B 13.01B 24.31B 1,655B 24.77B 171B 68.72B 870B 65.4B 64.01B 2,745B EV / Sales 2026 *
6.12x
EV / Sales 2027 * 5.62x
Free-Float
81.13%
Yield 2026 *
-
Yield 2027 * -
1 day-3.77%
1 week-2.57%
1 month+4.46%
3 months+12.98%
6 months+55.74%
Current year+16.09%
1 week 648.11
Extreme 648.1101
693.97
1 month 587.38
Extreme 587.385
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/10/26 Exercice

Chief Operating Officer

6,000 0.0215%
07/10/26 Exercice

Chief Operating Officer

4,000 0.0143%
30/09/26 Sell

Chief Executive Officer

-21,966 0.0787%
Change 5-day change 1-year change 3-year change Capi.($)
-3.77%-2.57%+11.47%+168.68% 18.24B
-0.62%-1.87%+42.87%+64.15% 63.77B
+0.35%+3.20%+14.40%+81.76% 56.37B
+0.53%+1.96%+16.24%+103.35% 54.62B
-2.81%-4.31%+23.50%+47.83% 44.06B
-0.33%-1.93%+19.28%+98.80% 42.11B
+0.55%+2.31%+225.14%+866.21% 41B
+3.27%+47.96%+112.84%+96.58% 34.92B
+1.22%-1.44%+14.57%+46.95% 32.82B
+0.89%+20.55%-40.62%+349.24% 24.7B
Average -0.07%+6.53%+43.97%+192.36% 41.26B
Weighted average by Cap. +0.00%+5.09%+46.38%+176.32%

Financials

2026 *2027 *
Net sales 2.85B 2.55B 2.35B 2.13B 3.98B 271B 4.05B 27.99B 11.24B 142B 10.69B 10.47B 449B 3.02B 2.71B 2.49B 2.26B 4.22B 287B 4.29B 29.68B 11.92B 151B 11.34B 11.1B 476B
Net income 521M 466M 429M 389M 726M 49.43B 740M 5.11B 2.05B 26B 1.95B 1.91B 81.99B 554M 496M 456M 413M 773M 52.58B 787M 5.44B 2.18B 27.66B 2.08B 2.03B 87.22B
Net Debt -812M -727M -669M -606M -1.13B -77.07B -1.15B -7.97B -3.2B -40.54B -3.05B -2.98B -128B -1.27B -1.14B -1.05B -950M -1.78B -121B -1.81B -12.5B -5.02B -63.55B -4.77B -4.67B -200B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
30/10/26 $652.01 -3.77% 219,452
29/10/26 $677.56 -2.18% 250,424
28/10/26 $692.68 +2.80% 301,522
27/10/26 $673.79 -0.44% 195,611
26/10/26 $676.77 +1.13% 306,534
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
652.01USD
Average target price
651.31USD
Spread / Average Target
-0.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medpace Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MEDP Stock